Reference ID: 2953262
Fidaxomicin is mainly confined to the gastrointestinal tract following oral administration. In selected patients (N=8) treated with DIFICID 200 mg twice daily for 10 days from
Download Reference ID: 2953262
Information
Domain:
Source:
Link to this page:
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
Oregon Medicaid Fee-for-Service PA Criteria
www.oregon.govOregon Medicaid PA Criteria 6 June 1, 2017 Introduction A bout this guide The Oregon Medicaid Pharmaceutical Services PA Criteria is designed to assist the following
Stanford Hospital & Clinics Antimicrobial Dosing Reference ...
med.stanford.eduStanford Hospital & Clinics Antimicrobial Dosing Reference Guide 2013 This document is also located on the SHC Intranet (http://portal.stanfordmed.org/depts/pharmacy ...
Surveillance, Diagnosis and Management of Clostridium ...
www.hpsc.ieNational Clinical Effectiveness Committee (NCEC) The National Clinical Effectiveness Committee (NCEC) was established as part of the Patient Safety First Initiative in September 2010.
MANAGEMENT OF C. DIFFICILE INFECTION
www.surgicalcriticalcare.net2 Approved 06/28/2015 DEFINITIONS Clostridium difficile infection (CDI) is diagnosed by the presence of at least one of the following (1): 1. Signs and symptoms of CDI plus microbiological evidence of infection (toxin or toxin-producing
C. difficile 감염 진단과 치료의 최신 지견
www.ekjm.org- 157 - C. difficile 감염: 진단과 치료의 최신 지견 한양대학교 의과대학 내과학교실 김 지 은 Essentials of Primary Care: 감염 Clostridium difficile 혐기성 그람 양성 간균으로, 독소를 생성하며 포자형태로
文獻回顧 困難梭狀桿菌腹瀉：治療困難之處
www.tsim.org.tw文獻回顧 困難梭狀桿菌腹瀉：治療困難之處 135 檢發現有偽膜性腸炎，或需要住加護病房，則 各得兩分。以上加總，若病人得 ...